Amgen Inc (NASDAQ:AMGN)

Friday’s trading has closed, but AMGN is being traded in the after-hours session. After-Hours quote »
144.01
Data as of 4:14pm ET
 +1.99 / +1.40%
Today’s Change
105.76
Today|||52-Week Range
144.46
+26.24%
Year-to-Date
3 Biotechs Investors Should Watch
1:51pm / MotleyFool.com
Biogen/AbbVie Report Positive Data on MS Drug Zinbryta - Analyst Blog
Sep 15 / Zacks.com
Stock Market News for September 19, 2014 - Market News
10:50am / Zacks.com
Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog
Sep 15 / Zacks.com
New Lifetime High Reached: Amgen (AMGN)
10:01am / TheStreet.com
Biogen Reports Positive Two-Year Data on MS Drug Plegridy - Analyst Blog
Sep 12 / Zacks.com
Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
Sep 18 / Zacks.com
Medivation-Astellas' Xtandi's Label Expanded by FDA - Analyst Blog
Sep 11 / Zacks.com
Europe struggles to catch US biotech bulls
Sep 18 / FT.com
Is This the Right Time to Buy Gilead Sciences (GILD) Stock? - Analyst Blog
Sep 11 / Zacks.com
Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog
Sep 17 / Zacks.com
Orexigen's Obesity Drug Contrave Approved by the FDA - Analyst Blog
Sep 11 / Zacks.com
UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
Sep 17 / Zacks.com
Why I'd Avoid Pfizer Inc. Stock Despite the Dividend
Sep 11 / MotleyFool.com
Amgen, Inc. Poised To Break Higher
Sep 17 / Benzinga
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - An...
Sep 10 / Zacks.com
3 Stocks Reiterated As A Buy: HAL, VZ, AMGN
Sep 17 / TheStreet.com
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Sep 10 / Zacks.com
Why Amgen Inc.'s Stock Is up 23% in 2014
Sep 17 / MotleyFool.com
Amgen Inc. (AMGN): New Analyst Report from Zacks Equity Research - Zacks Equity Resea...
Sep 08 / Zacks.com
Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog
Sep 16 / Zacks.com
3 Reasons Sanofi's Stock Could Fall
Sep 08 / MotleyFool.com
Is Illumina (ILMN) a Buy on Solid Q2, Strategic Road Map? - Analyst Blog
Sep 16 / Zacks.com
Biotech stocks buoyed by bullish broker
Sep 02 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.